CHC – The Cancer & Hematology Centers


Name of this trial: TROPION-Breast-05 What type of cancer is this for? Metastatic Triple Negative Breast Cancer  (TNBC) Who is this trial for? Patients who have recurrent, locally inoperable, metastatic breast cancer.  Must be ER-, PR-, HER2-.  What biomarkers are involved? PD-L1 positive What is the National Clinical Trial #? NCT06103864   Brief summary of this